Clinical Trial Update: Biomarker Analysis in Sorafenib Treated Hepatocellular Carcinoma Patients

View source ↗

Summary

This clinical trial update summarizes biomarker analyses conducted in hepatocellular carcinoma patients treated with sorafenib.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Nexavar (Sorafenib)

Snippet

Sponsor: Samsung Medical Center | Conditions: Hepatocellular Carcinoma | Status: COMPLETED